Dapagliflozin vs. Standard Care for the Prevention of Atrial Fibrillation Early Recurrence After Catheter Ablation in Patients With Persistent Atrial Fibrillation: Rationale and Design of the DARE-AF Trial
Atrial fibrillation (AF) recurrence remains common after catheter ablation, particularly in patients with persistent AF (PeAF). Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have been associated with a reduced risk of AF recurrence following ablation in patients with diabetes or heart failure. However, their...